EUVIMEDEUVIMED entdecken
Kohortenstudie

Correction to “Cohort Study of Pregnancy Outcomes After Exposure to Fexofenadine or Olopatadine in the First Trimester”

Congenital Anomalies · 2026-01 · 66 (1)

DOI: 10.1002/cga.70062 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift Congenital Anomalies, online erschienen am 12.05.2026.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

(2026). Correction to “Cohort Study of Pregnancy Outcomes After Exposure to Fexofenadine or Olopatadine in the First Trimester”. Congenital Anomalies, 66(1). https://doi.org/10.1002/cga.70062

Vancouver

Correction to “Cohort Study of Pregnancy Outcomes After Exposure to Fexofenadine or Olopatadine in the First Trimester”. Congenital Anomalies. 2026;66(1). doi:10.1002/cga.70062

BibTeX
@article{euvimed2026,
  title = {Correction to “Cohort Study of Pregnancy Outcomes After Exposure to Fexofenadine or Olopatadine in the First Trimester”},
  journal = {Congenital Anomalies},
  year = {2026},
  volume = {66},
  number = {1},
  doi = {10.1002/cga.70062}
}
Kostenlos starten →